Montelukast Prescribing at MOAT HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
537
Total Quantity
12.9K
NHS Cost
£1.6K
vs National Avg
-21.6%
MOAT HOUSE SURGERY prescribed 537 items of Montelukast over the last 12 months at a cost of £1,574 to the NHS. This is 21.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
51
Jul 2026
44
Jul 2026
38
Jul 2026
49
Jul 2026
41
Jul 2026
43
Jul 2026
43
Jul 2026
45
Jul 2026
49
Jul 2026
35
Jul 2026
53
Jul 2026
46
Prescribing Details
| Total Items | 537 |
|---|---|
| Total Quantity | 12,943 |
| Total NHS Cost | £1,574 |
| Presentations | 5 different forms |
| vs National Average | -21.6% |
Montelukast Prescribing Comparison
| This practice | 537 items |
|---|---|
| National average per practice | 685 items |
| Difference | -21.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.